Yang 2020d.
Study characteristics | |||
Patient Sampling |
Purpose: to identify differences in CT imaging and clinical features between COVID‐19 and
influenza pneumonia in the early stage, and to identify the most valuable features in the differential
diagnosis Design: diagnostic case‐control study, retrospective multicentre with historic control group Recruitment: cases: confirmed SARS‐CoV‐2 patients; controls: influenza pneumonia patients (1 January 2015‐30 September 2019 from 2 hospitals) Sample size: n = 121 (cases = 73) Inclusion criteria: patients confirmed with SARS‐CoV‐2; controls: patients who had 9 respiratory pathogen IgM antibody tested from January 2015‐September 2019 Exclusion criteria: cases: not specified controls:
No CT date, no clinical date |
||
Patient characteristics and setting |
Facility cases: positive RT‐PCR for 2019‐nCov Facility controls: influenza pneumonia Country: China Dates: 1 January 2020‐15 February 2020 Symptoms and severity: all patients in early stages of COVID‐19 or influenza pneumonia Demographics: M/F: cases 41/32, controls 30/18 mean age: cases 41.9, controls 40.4 Exposure history: not specified |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Time interval unclear | ||
Comparative | |||
Notes | Overlaps with Chen X 2020 | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Did the study avoid inappropriate inclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |